Neural Basis of Language Processing
BNL
The Neural Basis of Language: A New Lighting. Study of Semantic Processing in MRI Mutimodale and Direct Electrical Stimulation
1 other identifier
interventional
63
0 countries
N/A
Brief Summary
According to the O.M.S. Classification, grade 2 glioma is a pre-cancerous lesion, slowly progressive, infiltrating the central nervous system, mainly affecting young adults. This surgery should nevertheless be conducted in awake condition to achieve two conflicting goals: get maximum brain tissue infiltrated by the tumor while preserving the integrity of functional structures. So awake after opening the skull, the patient undergoes a series of preoperative tests, administered by a speech therapist present in the operating room. This procedure allows the neurosurgeon to establish an individual functional brain mapping in real time, through the observation by the SLP of the patient's answers to direct electrical stimulation applied to the cortical and sub-cortical. This support is based on the extraordinary plasticity demonstrated by the brain in the presence of a slowly progressive lesion. To ensure the patient the highest achievable load should increase our understanding of brain function, including the neural bases of language, glioma grade 2 is predominantly localized functional area of language.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 13, 2016
CompletedFirst Posted
Study publicly available on registry
September 16, 2016
CompletedSeptember 2, 2020
May 1, 2011
2.4 years
September 13, 2016
September 1, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
functional score
The intraoperative testing is performed by an evaluator (speech / neuropsychologist), present in the operating room, the patient's side. Its role is to identify functional disturbances induced by direct electrical stimulation. To do this, two standardized tests are administered to the patient alternately for the duration of the awake period. These tests are presented on a computer screen in PowerPoint format, with a picture every four seconds.
1 day
Secondary Outcomes (6)
Evaluation orthophonic
1 day
Evaluation orthophonic
5 day
Evaluation orthophonic
3 month
Imagery Data
1 day
Imagery Data
5 day
- +1 more secondary outcomes
Study Arms (2)
grade 2 glioma
OTHERPatient with grade 2 glioma use a neuropsychological examination and brain imaging (fMRI and tractography)
healthy volunteers
OTHERhealthy volunteers use a neuropsychological examination and brain imaging (fMRI and tractography)
Interventions
Patient with grade 2 glioma and healthy volunteers use a brain imaging (fMRI)
Patient with grade 2 glioma and healthy volunteers use a brain imaging (tractography)
Patient with grade 2 glioma and healthy volunteers use a neuropsychological examination
Eligibility Criteria
You may qualify if:
- Patients carry a grade glioma 2 functional area of language and presenting the information to receive surgical care provided in awake for the first time.
- or Healthy volunteers will be selected using a matching age and sex of patients in the study (matched to a patient on two of the first forty patients).
You may not qualify if:
- Subject presenting cons-indications to MRI (ventricular shunt valve, ferromagnetic foreign bodies, pacemaker, implantable defibrillators, cochlear hearing implant, claustrophobia, ....)
- History of head trauma, ischemic stroke or intracerebral hematoma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2016
First Posted
September 16, 2016
Study Start
September 1, 2012
Primary Completion
February 1, 2015
Study Completion
September 1, 2016
Last Updated
September 2, 2020
Record last verified: 2011-05